Transforming growth factor-β signaling pathway and targeted therapy in ovarian cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 562-565, 2019.
Article
in Chinese
| WPRIM
| ID: wpr-805841
ABSTRACT
The transforming growth factor-β (TGF-β) is a polypeptide cytokine, belonging to the TGF-β superfamily. TGF-β signaling pathway can regulate cell biological activity and play a bidirectional regulatory role in the development and progression of cancer. TGF-β signaling pathway can cause the occurrence and development of ovarian cancer through various processes including inducing cell excessive proliferation, influencing tumor microenvironment and regulating immune evasion. Targeted therapy with TGF-β as a biomar-ker for ovarian cancer provides a new way to improve the prognosis of patients.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS